NY-OPTIONMETRICS
OptionMetrics, an options database and analytics provider for institutional investors and academic researchers worldwide, is sponsoring and exhibiting at Europe EQD 2023, January 23-25, 2023, in Barcelona.
OptionMetrics offers the highest quality, most comprehensive coverage of equity, index, and ETF options on underlying stocks and indices worldwide. It will showcase its suite of IvyDB options databases to buysiders, quantitative analysts, and risk managers, including its:
- IvyDB US, covering 10,000+ underlying stocks and indices from 1996 onward.
- IvyDB Europe, covering 900+ optionable securities from exchanges in the UK, France, Germany, Switzerland, Netherlands, Sweden, Belgium, Spain, and Italy from 2002 onward.
- IvyDB Asia, covering 600 equities and indices from exchanges in Hong Kong, Japan, Taiwan, Korea, Australia from 2004 onward.
- IvyDB Canada, covering 300 optionable securities from Canadian exchanges from 2007 onward.
- IvyDB Futures, historical data on liquid optionable futures roots in agriculture, currency, energy, equity, interest rate, and metals sectors since January 2005 on most U.S. futures exchanges.
- IvyDB Signed Volume, covering option trading volume and order flows from institutional and retail trading from 2016 onward.
“Today’s complex, fast-paced markets call for high-quality data to assess opportunities and financial risk,” said OptionMetrics CEO David Hait, Ph.D. “Leading researchers, quantitative analysts, and risk managers at investment banks, hedge funds, and pension funds worldwide look to OptionMetrics as the gold standard in options data to examine market trends and variances, evaluate risk exposure, and test strategies with greater confidence. We look forward to connecting with many of them at this event.”
Europe EQD is a leading multi-asset, volatility, ESG, and cross-asset systematic investing forum for institutional investors. Presentations focus on multi-asset investing, volatility, fixed income, global macro and traditional alternatives, and more.
Contact William Ko to schedule an appointment with OptionMetrics at the conference.
About OptionMetrics
With 20+ years as the premier provider of historical options and implied volatility data, OptionMetrics distributes its IvyDB options and futures databases to leading portfolio managers, traders, quantitative researchers at 300+ corporate and academic institutions worldwide to construct and test investment strategies, perform empirical research, assess risk. www.optionmetrics.com, LinkedIn, Twitter
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230117005267/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Planet Awarded €240 Million Satellite Services Deal1.7.2025 15:03:00 CEST | Press release
Planet Labs Germany GmbH, a leading provider of daily data and insights about Earth, today announced a multi-year €240 million agreement, funded by the German government, in support of European peace and security. Through the agreement, Planet will provide dedicated capacity and direct downlink services on Pelican satellites over specific European regions. This deal also includes access to PlanetScope and SkySat data, along with AI-enabled solutions for enhanced situational awareness and maritime domain awareness. The contract will provide high-resolution imagery and timely intelligence via dedicated capacity on Pelican satellites, including those being built for our previously announced satellite services agreement. This satellite services ‘dedicated capacity’ model offers a cost-effective and efficient way for customers to gain access to advanced space-based capabilities without the operational complexities of building and maintaining their own satellite infrastructure. “We are incre
Esports World Cup Foundation and Lenovo™ Partner to Power the Next Generation of Esports Champions1.7.2025 15:00:00 CEST | Press release
Lenovo’s Legion premium gaming brand joins the world’s largest esports event to fuel elite performance and elevate the fan experience through world-class hardware.[Media Kit] The Esports World Cup Foundation (EWCF) and Lenovo today announced a partnership to make Lenovo’s Legion brand of gaming devices the Official PC & Gaming Hardware partner of the Esports World Cup 2025 (EWC). Lenovo Legion is the one of the world’s leading gaming ecosystem brands, and will be bring its relentless commitment to innovation and performance to the global stage, empowering EWC athletes to compete at their highest level. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250626760677/en/ From training rooms to tournament zones, EWC athletes will be equipped with Lenovo Legion Towers, Lenovo Legion laptops, and peripherals – built for elite esports play with advanced thermal systems, high-performance silicon, high refresh-rate displays and low late
Citigroup Announces €1.75 Billion Redemption of 1.250% Fixed Rate/Floating Rate Notes Due 20261.7.2025 14:30:00 CEST | Press release
Citigroup Inc. is announcing the redemption, in whole, constituting €1,750,000,000 of its 1.250% Fixed Rate/Floating Rate Notes due 2026 (the “notes”) (ISIN: XS2167003685). The redemption date for the notes is July 6, 2025 (the “redemption date”). The cash redemption price for the notes payable on the redemption date will equal par plus accrued and unpaid interest, to but excluding, the redemption date and will be paid on July 7, 2025, the next succeeding business day after the redemption date. The redemption announced today is consistent with Citigroup's liability management strategy and reflects its ongoing efforts to enhance the efficiency of its funding and capital structure. Citigroup will continue to consider opportunities to redeem or repurchase securities, based on several factors, including without limitation, the economic value, regulatory changes, potential impact on Citigroup's net interest margin and borrowing costs, the overall remaining tenor of Citigroup's debt portfoli
LevelBlue to Acquire Trustwave, Becoming Largest Pure-Play Managed Security Services Provider1.7.2025 14:00:00 CEST | Press release
LevelBlue Strengthens Market-Leading Managed Detection and Response Services with Advanced AI Capabilities, While Adding Prestigious FedRAMP and StateRAMP Authorizations LevelBlue, a global leader in cloud-based, AI-driven managed security services (MSS), has signed a definitive agreement to acquire Trustwave, a global provider of cybersecurity and managed detection and response (MDR) services from the MC2 Security Fund (MC2), a private equity fund sponsored by The Chertoff Group, an internationally recognized security and growth advisory firm. This strategic acquisition complements LevelBlue’s recent agreement to acquire Aon’s cybersecurity consulting business, formerly known as Stroz Friedberg, and further strengthens the company’s market leadership, uniting two leading Managed Security Service Providers (MSSPs) to deliver unparalleled cybersecurity outcomes through a comprehensive and expanded suite of services designed to stay ahead of the rapidly evolving threat landscape. The acq
Vertex Announces European Commission Approval of ALYFTREK®, a New Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis1.7.2025 13:34:00 CEST | Press release
- ALYFTREK® (deutivacaftor/tezacaftor/vanzacaftor) approved in the EU for people with CF 6 years and older with at least one non-class I mutation in the CFTR gene, making it the broadest label for this medicine in the world -- In head-to-head clinical trials, deutivacaftor/tezacaftor/vanzacaftor was non-inferior on ppFEV1 and superior compared to KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) at reducing sweat chloride, demonstrating greater improvement in CFTR function -- Approximately 31,000 people with CF in the EU are now eligible for this new highly effective modulator therapy - Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for ALYFTREK®(deutivacaftor/tezacaftor/vanzacaftor)for the treatment of people with cystic fibrosis (CF) ages 6 years and older who have at least one non-class I mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. “Thousands of people with CF across the EU may now benefit from t
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom